SCHEMBL4337634

SCHEMBL4337634

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CI

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4337670 1.00 LMNA (0.38) LMNATHRB
SCHEMBL25685789 1.00 LMNA (0.38) LMNATHRB
SCHEMBL20848204 1.00 LMNA (0.38) LMNATHRB
SCHEMBL810559 1.00 LMNA (0.38) LMNATHRB
SCHEMBL28597147 0.97 LMNA (0.33) LMNA
SCHEMBL4182547 0.87
SCHEMBL10300018 0.87
SCHEMBL25685341 0.80
SCHEMBL3022678 0.79
SCHEMBL14780804 0.78 LMNA (0.32) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612166-B2 Fluorous capping reagents and methods for peptide purification TRUSTEES OF TUFTS COLLEGE (US) 2009-11-03 US disclosed
US-20080275216-A1 Fluorous Capping Reagents and Methods for Peptide Purification TRUSTEES OF TUFTS COLLEGE (US) 2008-11-06 US disclosed
WO-2005118527-A2 FLUOROUS CAPPING REAGENTS, AND METHODS FOR PEPTIDE PURIFICATION TRUSTEES OF TUFTS COLLEGE (US) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275216-A1 Fluorous Capping Reagents and Methods for Peptide Purification DNPEP, ANPEP, RNGTT LMNA 4148/4885THRB 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.